No Picture
News

Akebia Therapeutics Announces September 2021 Investor Conference Schedule

CAMBRIDGE, Mass.: CAMBRIDGE, Mass., Sept. 1, 2021 /PRNewswire/ — Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, and David A. Spellman, Chief Financial Officer, will participate in the… Click here to view original post… […]

No Picture
News

TeselaGen Biotechnology Teams Up with iGEM to Advance Synthetic Biology in Developing Countries

SAN FRANCISCO and CAMBRIDGE, Mass.: SAN FRANCISCO and CAMBRIDGE, Mass., Sept. 1, 2021 /PRNewswire-PRWeb/ — TeselaGen Biotechnology announced today that it has partnered with the iGEM Foundation to support the iGEM Design League, a new competition that aims to advance synthetic biology, starting with Latin America. As part of the… Click here to view original post… […]